[1]
M. De Francesco, M. Lamotte, P. A. Ascierto, P. Di Rienzo, and Y. Asukai, “Economic Evaluation of Ipilimumab in First Line Treatment of Advanced Melanoma in Italy”, Grhta, vol. 3, no. 2, pp. 67–79, Jul. 2016.